Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 08, 2021

SELL
$85.88 - $105.36 $10,735 - $13,170
-125 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$72.74 - $92.5 $9,092 - $11,562
125 New
125 $10,000
Q4 2018

Jan 28, 2019

SELL
$29.95 - $46.34 $9,853 - $15,245
-329 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$38.72 - $42.52 $12,738 - $13,989
329 New
329 $13,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Flagship Harbor Advisors, LLC Portfolio

Follow Flagship Harbor Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.